ALDH2通过cGAS/STING通路减轻LPS诱导的心脏功能障碍,炎症和亡
Haoran Liu1,2, Qin Hu1,2, Ke Ren3
1Emergency and Trauma College, Hainan Medical University, Haikou, China.
Molecular medicine (Cambridge, Mass.)
|December 21, 2023
概括
线粒体阿尔德海德脱酶2 (ALDH2) 通过抑制cGAS/STING通路,保护免受败血症引起的心脏功能障碍. 激活ALDH2为败血症诱导的心肌病症提供了潜在的治疗策略.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 败血症是一种危及生命的疾病,通常会导致心脏功能障碍.
- 线粒体脱酶2 (ALDH2) 在脂聚糖 (LPS) 诱导的心肌损伤中的作用尚不清楚.
- 这项研究研究了ALDH2在LPS引起的心脏损伤中的功能及其调节机制.
研究的目的:
- 评估ALDH2在LPS引起的心肌损伤中的作用.
- 在此背景下阐明ALDH2的调节机制.
- 为了确定毒引起的心肌病的潜在治疗策略.
主要方法:
- 在体内 (小鼠) 和体外 (H9C2细胞) 建立了LPS诱导的心脏损伤模型.
- 使用ALDH2激活剂 (Alda-1) 和抑制剂 (daidzin) 来评估治疗效果.
- 评估心脏功能,炎症,亡和氧化应激,使用诸如回声心电图,ELISA,流细胞计和西式涂抹等技术.
- 通过siRNA敲除,研究了循环GMP-AMP合成酶 (cGAS) 的作用.
主要成果:
- LPS诱导心脏功能障碍,心脏损伤标志物 (CKMB,LDH) 升高,活性氧物种 (ROS) 增加,并促进炎症和亡.
- 用Alda-1激活ALDH2,通过抑制cGAS/STING信号通路,扭转了LPS诱导的心脏损伤.
- 在心肌细胞中抑制cGAS减弱了LPS诱导的炎症,亡和ROS产生.
结论:
- ALDH2通过cGAS/STING通路对LPS诱导的心脏功能障碍,炎症和亡起着保护作用.
- 向ALDH2代表了针对败血症诱导心肌病 (SIC) 的新型治疗方法.
- 这项研究提供了对毒引起的心脏损伤背后的分子机制的见解.
关键词:
这就是ALDH2的原因.细胞灭亡 (apoptosis) 是一种死亡的过程.心脏功能障碍是因为心脏功能障碍.炎症 炎症是一种炎症.脂聚糖类糖化物 脂聚糖类糖化物cGAS/STING的使用情况.更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.5K
06:12Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
1.9K
相关概念视频
01:12GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:09GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K